Jean Claude Tardif

Summary

Affiliation: Montreal Heart Institute
Country: Canada

Publications

  1. ncbi Apolipoprotein B antisense inhibition -update on mipomersen
    Catherine Gebhard
    Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada
    Curr Pharm Des 19:3132-42. 2013
  2. ncbi Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network
    Jean Claude Tardif
    Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 29:297-303. 2013
  3. ncbi An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels
    David Rhainds
    Atherosclerosis Research Group, Montreal Heart Institute, 5000 Belanger St, Montreal, Quebec, Canada
    Future Cardiol 8:513-31. 2012
  4. ncbi Optimus Primer: A PCR enrichment primer design program for next-generation sequencing of human exonic regions
    Andrew Mk Brown
    Universite de Montreal, Montreal, Quebec, Canada
    BMC Res Notes 3:185. 2010
  5. ncbi Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension
    Jean Claude Tardif
    Montreal Heart Institute, Montreal H1T IC8, Canada
    Clin Ther 26:1073-83. 2004
  6. ncbi Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial
    Jean Claude Tardif
    Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Atherosclerosis 197:480-6. 2008
  7. ncbi Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial
    Jean Claude Tardif
    Montreal Heart Institute and the Montreal Heart Institute Coordinating Center, Universite de Montreal, Montreal, Quebec, Canada
    JAMA 297:1675-82. 2007
  8. ncbi Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Canada
    J Thorac Cardiovasc Surg 133:1604-11. 2007
  9. ncbi Clinical results of I(f) current inhibition by ivabradine
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Quebec, Canada
    Drugs 67:35-41. 2007
  10. ncbi Atherosclerosis imaging
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Quebec
    Can J Cardiol 21:1035-9. 2005

Collaborators

Detail Information

Publications130 found, 100 shown here

  1. ncbi Apolipoprotein B antisense inhibition -update on mipomersen
    Catherine Gebhard
    Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada
    Curr Pharm Des 19:3132-42. 2013
    ..If future studies continue to show such promising results, mipomersen would likely be a viable additional lipid-lowering therapy for high-risk populations...
  2. ncbi Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network
    Jean Claude Tardif
    Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Can J Cardiol 29:297-303. 2013
    ..The benefits are expected to appear in the next 2 to 3 years. CAIN will drive innovation in imaging technology within the field of cardiology and neurology and improve health outcomes in Canada and worldwide...
  3. ncbi An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels
    David Rhainds
    Atherosclerosis Research Group, Montreal Heart Institute, 5000 Belanger St, Montreal, Quebec, Canada
    Future Cardiol 8:513-31. 2012
    ....
  4. ncbi Optimus Primer: A PCR enrichment primer design program for next-generation sequencing of human exonic regions
    Andrew Mk Brown
    Universite de Montreal, Montreal, Quebec, Canada
    BMC Res Notes 3:185. 2010
    ....
  5. ncbi Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension
    Jean Claude Tardif
    Montreal Heart Institute, Montreal H1T IC8, Canada
    Clin Ther 26:1073-83. 2004
    ..There is controversy regarding the impact that different antihypertensive regimens, including modern combination therapy, have on the incidence of myocardial infarction, other cardiovascular events, and mortality...
  6. ncbi Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial
    Jean Claude Tardif
    Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Atherosclerosis 197:480-6. 2008
    ..The present study originally intended to study restenosis as a primary endpoint but was subsequently modified to primarily investigate the effects of AGI-1067 on coronary atherosclerosis...
  7. ncbi Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial
    Jean Claude Tardif
    Montreal Heart Institute and the Montreal Heart Institute Coordinating Center, Universite de Montreal, Montreal, Quebec, Canada
    JAMA 297:1675-82. 2007
    ..High-density lipoprotein (HDL) cholesterol is an inverse predictor of coronary atherosclerotic disease. Preliminary data have suggested that HDL infusions can induce atherosclerosis regression...
  8. ncbi Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Canada
    J Thorac Cardiovasc Surg 133:1604-11. 2007
    ..The MEND-CABG trial tested the hypothesis that MC-1 reduces cardiovascular morbidity and mortality after coronary artery bypass graft...
  9. ncbi Clinical results of I(f) current inhibition by ivabradine
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Quebec, Canada
    Drugs 67:35-41. 2007
    ....
  10. ncbi Atherosclerosis imaging
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Quebec
    Can J Cardiol 21:1035-9. 2005
    ..IVUS can also help to determine dose-response relationships in the development of novel pharmacological agents. IVUS is currently the ideal imaging modality for clinical trials examining the progression or regression of atherosclerosis...
  11. ncbi Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions
    Jean Claude Tardif
    Montreal Heart Institute, 5000 Belanger St, Montreal, H1T 1C8, Canada
    Circulation 110:3372-7. 2004
    ..The ACAT inhibitor avasimibe was shown to reduce experimental atherosclerosis. This study was designed to investigate the effects of avasimibe on human coronary atherosclerosis...
  12. ncbi Antioxidants and atherosclerosis: emerging drug therapies
    Jean Claude Tardif
    MHI Research Center, Montreal Heart Institute, Montreal, Quebec H1T 1C8, Canada
    Curr Atheroscler Rep 7:71-7. 2005
    ....
  13. ncbi Prevention challenges: the era of atherosclerosis regression
    Jean Claude Tardif
    Montreal Heart Institute, and Université de Montréal, Montreal, Quebec
    Can J Cardiol 22:27C-30C. 2006
    ..The additional cardiovascular protection required for patients with atherosclerosis or risk equivalents will likely be provided by therapies that go beyond LDL reduction...
  14. ncbi Vascular biomarkers and surrogates in cardiovascular disease
    Jean Claude Tardif
    Montreal Heart Institute, Universite de Montreal, 5000 Belanger St, Montreal, H1T 1C8, Canada
    Circulation 113:2936-42. 2006
    ..The information presented in the present report summarizes the authors' perspective distilled from these proceedings...
  15. ncbi Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound
    Jean Claude Tardif
    Department of Medicine and Research Center of the Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 98:23-7. 2006
    ..This reverse vascular remodeling may be responsible for the "regression paradox," whereby secondary prevention is associated with clinical benefits despite minimal improvement in coronary lumen dimensions...
  16. ncbi Antioxidants: the good, the bad and the ugly
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Quebec
    Can J Cardiol 22:61B-65B. 2006
    ....
  17. ncbi Cardiac investigation in patients with diabetes
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec
    Can J Cardiol 22:38A-40A. 2006
    ..Official guidelines for appropriate and cost-effective cardiac investigation should help physicians manage diabetic patients...
  18. ncbi Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
    Jean Claude Tardif
    Montreal Heart Institute, University of Montreal, Montreal, Canada
    Lancet 371:1761-8. 2008
    ..Our aim was to assess the effects of the antioxidant succinobucol (AGI-1067) on cardiovascular outcomes in patients with recent acute coronary syndromes already managed with conventional treatments...
  19. ncbi Reaching the therapeutic goal in hypertension: results from the Canadian valsartan observational study. (Diovantage 4)
    Jean Claude Tardif
    Department of Medicine and Research Center, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Can J Clin Pharmacol 15:e177-87. 2008
    ..Hypertension is a leading cause of death worldwide, and a major public health problem in Canada. Despite treatment guidelines and availability of therapies for blood pressure (BP) management, treatment of hypertension remains sub-optimal...
  20. ncbi Imaging biomarkers of atherosclerosis
    Stephane Noble
    Montreal Heart Institute, 5000 Belanger Street, Montreal, PQ, H1T 1C8, Canada
    Biomark Med 2:555-65. 2008
    ..These technologies include traditional imaging such as angiography, as well as advanced imaging techniques using both invasive and noninvasive approaches...
  21. ncbi Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
    Jean Claude Tardif
    Montreal Heart Institute, Universite de Montreal, 5000 Belanger Street, Montreal, Quebec, Canada H1T 1C8
    Eur Heart J 32:2507-15. 2011
    ..The SHIFT echocardiographic substudy evaluated the effects of ivabradine on left ventricular (LV) remodelling in heart failure (HF)...
  22. ncbi Heart rate as a treatable cardiovascular risk factor
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, QC, Canada H1T 1C8
    Br Med Bull 90:71-84. 2009
    ..Although several epidemiological studies demonstrate the association between resting heart rate (HR) and cardiovascular morbidity and mortality, an elevated HR remains a neglected cardiovascular risk factor...
  23. ncbi Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
    Jean Claude Tardif
    Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Eur Heart J 30:540-8. 2009
    ..To evaluate the anti-anginal and anti-ischaemic efficacy of the selective I(f) current inhibitor ivabradine in patients with chronic stable angina pectoris receiving beta-blocker therapy...
  24. ncbi Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases
    Jean Claude Tardif
    Montreal Heart Institute, University of Montreal, Montreal, QC, Canada
    Drugs Today (Barc) 44:171-81. 2008
    ..Ongoing studies will determine the potential of pure heart rate reduction with ivabradine to improve morbidity and mortality...
  25. ncbi Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?
    Jean Claude Tardif
    Department of Medicine, Research Centre, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T1C8, Canada
    J Clin Lipidol 4:399-404. 2010
    ..Taken together, this evidence suggests that infusions of HDL or apoA-1 may reduce events, particularly among patients with ACS...
  26. ncbi A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Circ Cardiovasc Interv 3:543-8. 2010
    ..Our objective was to evaluate the safety and efficacy of Serp-1 in patients with ACS undergoing percutaneous coronary intervention...
  27. ncbi Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression
    Colin Berry
    Department of Medicine, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Circulation 115:1851-7. 2007
    ..To explore this subject further, we analyzed the angiographic and IVUS data derived from a contemporary clinical trial population...
  28. ncbi Effects of AGI-1067 and probucol after percutaneous coronary interventions
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Canada
    Circulation 107:552-8. 2003
    ..In a multicenter trial, we studied whether AGI-1067 reduces restenosis assessed by intravascular ultrasound (IVUS) after percutaneous coronary intervention (PCI) compared with placebo and probucol used as a positive control...
  29. ncbi Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery
    Yanick Beaulieu
    Department of Medicine, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Anesthesiology 112:128-37. 2010
    ....
  30. ncbi Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice
    Virginie Bolduc
    Department of Pharmacology, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada
    Am J Physiol Heart Circ Physiol 301:H2081-92. 2011
    ..In conclusion, HR-dependent mechanical stress contributes to carotid artery wall stiffening in severely dyslipidemic mice while cerebrovascular compliance is mostly regulated by the endothelium...
  31. ncbi Left and right ventricular diastolic dysfunction as predictors of difficult separation from cardiopulmonary bypass
    Andre Y Denault
    Department of Anesthesia, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec H1T 1C8, Canada
    Can J Anaesth 53:1020-9. 2006
    ....
  32. ncbi Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial
    Eileen O'Meara
    Montreal Heart Institute, Montreal Heart Institute Coordinating Center, and Université de Montréal, Montreal, QC, Canada
    Circ Heart Fail 5:586-93. 2012
    ..Our primary objective was to assess the impact of mineralocorticoid receptor antagonists on cardiovascular mortality in patients with AF and HF enrolled in the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial...
  33. ncbi Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies
    Jean Claude Tardif
    Montreal Heart Institute, 5000 Belanger Street, Montreal, PQ, H1T 1C8, Canada
    Curr Opin Lipidol 14:615-20. 2003
    ....
  34. ncbi Preliminary experience in the use of preoperative echo-guided left stellate ganglion block in patients undergoing cardiac surgery
    Sébastien Y Garneau
    Department of Anesthesiology, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Cardiothorac Vasc Anesth 25:78-84. 2011
    ..Thus, the goal of the study was to test the hypothesis that echo-guided left SGB, performed before the induction of general anesthesia, could prevent PA pressure increases during CPB weaning...
  35. ncbi Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery
    Pierre Couture
    Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada
    Can J Anaesth 54:509-22. 2007
    ..To evaluate the effect of milrinone on diastolic function during coronary artery bypass grafting surgery (CABG)...
  36. ncbi Incidence and significance of abnormal hepatic venous Doppler flow velocities before cardiac surgery
    Maïté Carricart
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    J Cardiothorac Vasc Anesth 19:751-8. 2005
    ..The purpose of this study was to determine the incidence and significance of abnormal hepatic Doppler venous flow velocities as signs of an abnormal right ventricular filling pattern before cardiac surgery...
  37. ncbi Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy
    Jessica Forcillo
    Cardiac Surgery, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Cardiovasc Pharmacol 58:295-306. 2011
    ..05). In this swine model of LVH, atorvastatin did not prevent LVH development or coronary endothelial dysfunction and resulted in worsening of the LV diastolic dysfunction...
  38. ncbi Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial
    Jean Claude Tardif
    Montreal Heart Institute, Montreal, Quebec, Canada
    Am Heart J 144:589-96. 2002
    ..In addition to ACAT inhibitor monotherapy, combination of a statin with an ACAT inhibitor may be a promising approach to further prevent the progression of atherosclerosis...
  39. ncbi Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery
    Francois Haddad
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Soc Echocardiogr 20:1065-72. 2007
    ..The main objective of this study is to assess the prognostic value of RVMPI and RVFAC in predicting postoperative mortality or circulatory failure...
  40. ncbi Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis
    David Busseuil
    Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Cardiology 117:234-42. 2010
    ..To determine if heart rate (HR) reduction with ivabradine (IVA), a selective inhibitor of the pacemaker I(f) current, prevents cardiac dysfunction associated with dyslipidemia...
  41. ncbi Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models
    Kunihiro Nishida
    Department of Medicine and Research Center, Montreal Heart Institute and Universite de Montreal, Quebec, Canada
    Circ Arrhythm Electrophysiol 5:1168-75. 2012
    ..This study assessed effects of AF-related remodeling on the atrial thrombogenic milieu by using radiofrequency ablation (RFA) to create a quantifiable prothrombotic nidus...
  42. ncbi Enlargement of catheter ablation lesions in infant hearts with cryothermal versus radiofrequency energy: an animal study
    Paul Khairy
    Electrophysiology Service and Research Center, Montreal Heart Institute, Universite de Montreal, Canada
    Circ Arrhythm Electrophysiol 4:211-7. 2011
    ..It remains unknown whether cryothermal ablation lesions display a similar pattern of growth...
  43. ncbi Inhaled milrinone: a new alternative in cardiac surgery?
    Andre Y Denault
    Department of Cardiac Anesthesiology, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Semin Cardiothorac Vasc Anesth 10:346-60. 2006
    ..Therefore, this approach could represent an alternative to nitric oxide. This current state of knowledge of intravenous and inhaled milrinone is presented and summarized...
  44. ncbi Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management
    Colin Berry
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 49:631-42. 2007
    ..Noncompliance, particularly with lifestyle measures, and underprescription of evidence-based therapies remain important unsolved problems...
  45. ncbi Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery
    Dominique Piquette
    Department of Anesthesiology and Research Center, Montreal Heart Institute and Universite de Montreal, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada
    Can J Anaesth 54:718-27. 2007
    ..To determine whether or not intravenous nitroglycerin (IV NTG) can prevent a decrease in near-infrared spectroscopy (NIRS) values during cardiopulmonary bypass (CPB)...
  46. ncbi Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome
    Jean Claude Tardif
    Department of Medicine, Radiology, Montreal Heart Institute and Universite de Montreal, Montreal, Canada
    Circ Cardiovasc Imaging 3:298-307. 2010
    ..Production of leukotrienes by 5-lipoxygenase (5-LO) has been linked to unstable atherosclerotic plaques and cardiovascular events. VIA-2291 is a potent 5-LO inhibitor...
  47. ncbi Prevention of restenosis with antioxidants: mechanisms and implications
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Am J Cardiovasc Drugs 2:323-34. 2002
    ....
  48. ncbi Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina
    Jean Claude Tardif
    Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada
    Eur Heart J 26:2529-36. 2005
    ..Ivabradine has shown anti-ischaemic and anti-anginal activity in a placebo-controlled trial. The objective of this study was to compare the anti-anginal and anti-ischaemic effects of ivabradine and the beta-blocker atenolol...
  49. ncbi Vascular protectants for the treatment of atherosclerosis
    Jean Claude Tardif
    Montreal Heart Institute, 5000 Belanger Street, Montreal, PQ, H1T 1C8, Canada
    Expert Rev Cardiovasc Ther 1:385-92. 2003
    ....
  50. ncbi Poor correlation between hemodynamic and echocardiographic indexes of left ventricular performance in the operating room and intensive care unit
    Marie Josée Bouchard
    Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada
    Crit Care Med 32:644-8. 2004
    ..To compare hemodynamic and echocardiographic indexes of left ventricular performance...
  51. ncbi Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries
    Antoine Guédès
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    J Am Coll Cardiol 45:559-64. 2005
    ..The goal of this study was to demonstrate that intravascular ultrasound (IVUS) examination of native coronary arteries does not result in an acceleration of the atherosclerotic process...
  52. ncbi Heart rate recovery after exercise and long-term prognosis in patients with coronary artery disease
    Mathieu Gayda
    Montreal Heart Institute Cardiovascular and Prevention Centre Centre ÉPIC, Montreal, Quebec, Canada
    Can J Cardiol 28:201-7. 2012
    ..The long-term prognostic value of heart rate recovery (HRR) has been incompletely documented in patients with coronary artery disease (CAD). We sought to confirm the prognostic value of HRR in a large cohort with stable CAD...
  53. ncbi Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD
    Simon de Denus
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Can J Cardiol 24:45-8. 2008
    ..Currently, the relationship between temporal variations in hematocrit and specific causes of mortality and morbidity, as well as the most appropriate way to monitor changes in hematocrit, is unknown...
  54. ncbi Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice
    Khai Le Quang
    Research Center and Departments of Medicine, Université de Montréal and Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec, Canada
    Cardiovasc Res 91:420-8. 2011
    ..To clarify the role of I(CaT) in cardiac remodelling, we studied mice with either of the principal cardiac I(CaT)-subunits (Cav3.1 or Cav3.2) knocked out...
  55. ncbi Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)
    Jocelyn Dupuis
    The Research Center of the Montreal Heart Institute and the Department of Medicine of the University of Montreal, Montreal, Quebec, Canada
    Am J Cardiol 96:1207-13. 2005
    ..140) and NMD (p = 0.129). In conclusion, initiation of statin therapy soon after ACS is associated with improvements in endothelium-dependent and independent vascular reactivities after 4 months...
  56. ncbi Intravascular ultrasound assessment of atherosclerosis
    Antoine Guédès
    Department of Medicine, Montreal Heart Institute, 5000 Belanger Street, Montreal H1T 1C8, Canada
    Curr Atheroscler Rep 6:219-24. 2004
    ..IVUS can also help to determine dose-response relationships in the development of novel pharmacologic agents. IVUS is currently the ideal imaging modality for clinical trials of atherosclerosis progression/regression...
  57. ncbi Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies
    Remi Kouz
    University of Montreal, Canada
    Int J Cardiol 153:249-55. 2011
    ..The objective of this study is to evaluate the effectiveness and safety of GPI, as adjuvant therapy for primary PCI in real-life patients with myocardial infarction with ST segment elevation (STEMI) from the general population...
  58. ncbi Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure
    Andreanne Chabot
    Research Center, Montreal Heart Institute Université de Montréal, 5000 Belanger Street, Montreal, Quebec, H1T 1C8, Canada
    BMC Cardiovasc Disord 11:72. 2011
    ..We hypothesized that aldosterone contributes to pulmonary remodelling and right ventricular (RV) dysfunction associated with CHF by stimulation of lung myofibroblasts (MYFs) proliferation...
  59. ncbi Dynamic right ventricular outflow tract obstruction in cardiac surgery
    Andre Y Denault
    Department of Anesthesiology, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada
    J Thorac Cardiovasc Surg 132:43-9. 2006
    ..Right ventricular outflow tract obstruction can be a cause of hemodynamic instability but it has not been described in non-congenital cardiac surgery...
  60. ncbi Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction
    Bao Hua Jiang
    Research Center, Montreal Heart Institute, Universite de Montreal, Montreal, Quebec, Canada
    Cardiovasc Pathol 20:e85-9. 2011
    ..Early prediction of infarct size and of the subsequent development of congestive heart failure (CHF) and pulmonary hypertension (PH) would be useful in therapeutic trials using the rat myocardial infarction (MI) model...
  61. ncbi Coronary heart disease in patients with diabetes: part II: recent advances in coronary revascularization
    Colin Berry
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 49:643-56. 2007
    ..Improvements in PCI and coronary artery bypass graft surgery are leading to better results in diabetic patients, and clinical trials are presently comparing contemporary PCI with surgery...
  62. ncbi Pooled DNA resequencing of 68 myocardial infarction candidate genes in French canadians
    Melissa Beaudoin
    Montreal Heart Institute, 5000 rue Belanger, Montreal, Quebec, Canada
    Circ Cardiovasc Genet 5:547-54. 2012
    ..Except for a few examples (eg, PCSK9), the role of low-frequency genetic variation (minor allele frequency [MAF]) ≈0.1%-5% on MI/coronary artery disease predisposition has not been extensively investigated...
  63. ncbi Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea
    Yu Ki Iwasaki
    Department of Medicine and Research Center, Montreal Heart Institute, Quebec, Canada
    Heart Rhythm 9:1409-16.e1. 2012
    ..Obesity and obstructive sleep apnea (OSA) are risk factors for atrial fibrillation (AF), but the underlying mechanisms are poorly understood...
  64. ncbi Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease
    Colin Berry
    Department of Medicine, Montreal Heart Institute Université de Montréal, Montreal, Quebec, Canada
    Am Heart J 160:188-194.e1. 2010
    ..Left main coronary artery (LMCA) disease influences survival; however, the predictors of LMCA changes over time are incompletely understood...
  65. ncbi Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress
    Joanna Rossi
    Dept of Chemical Engineering, McGill University, 3610 University Street, Montreal, QC, Canada
    Life Sci 87:92-9. 2010
    ..In this study, we investigated the combined effect of laminar shear stress (LSS) and statins on endothelial cell gene expression...
  66. ncbi Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions
    Stephane Noble
    Department of Medicine, Montreal Heart Institute, Universite de Montreal, Montreal, Canada
    EuroIntervention 5:244-9. 2009
    ..We describe a new imaging technique consisting of rotational angiography combined with rapid pacing to obtain real-time, high-quality, three-dimensional images in the catheterisation laboratory...
  67. ncbi Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors
    Ba Khoi Nguyen
    Cardiac Surgery, Montreal University Hospital Centre CHUM, Montreal, QC, Canada
    J Cardiovasc Transl Res 3:547-58. 2010
    ..MSC-derived growth factors injection (rather than MSC themselves) should be evaluated as a novel therapy to treat ischemic heart disease, avoiding many practical and technical issues of cell therapy...
  68. ncbi Cardiac pathways distinguish two epistatic modules enacting BP quantitative trait loci and candidate gene analysis
    Cristina Chauvet
    Research Centre, Centre Hospitalier de l Universite de Montreal, Universite de Montreal, Montreal, Quebec, Canada
    Hypertens Res 32:631-7. 2009
    ..The identification of the six QTLs will likely develop into a novel diagnostic and/or therapeutic target for essential hypertension and hypertension-associated diseases...
  69. ncbi Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies
    Martial G Bourassa
    Department of Medicine and Research Center, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8
    J Am Coll Cardiol 41:351-9. 2003
    ..Successful medical, interventional, or surgical therapy leads not only to marked improvement or normalization of these alterations but also relief of angina and ischemia...
  70. ncbi Distinct genomic replacements from Lewis correct diastolic dysfunction, attenuate hypertension, and reduce left ventricular hypertrophy in Dahl salt-sensitive rats
    Alan Y Deng
    Research Centre, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    J Hypertens 26:1935-43. 2008
    ..Diastolic dysfunction often represents the onset of diastolic heart failure...
  71. ncbi Heart rate slowing versus other pharmacological antianginal strategies
    Ariel Diaz
    Montreal Heart Institute, Montreal, Canada
    Adv Cardiol 43:65-78. 2006
    ....
  72. ncbi Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts
    Benjamin Lauzier
    Departments of Nutrition, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Am J Physiol Heart Circ Physiol 300:H845-52. 2011
    ..Our results provide the impetus for testing selective HRR by IVA on cardiac substrate metabolism in pathological models...
  73. ncbi Is there an association between coronary atherosclerosis and airway responsiveness?
    Julie Turmel
    Laval Hospital Quebec Heart Lung Institute, Quebec City, Montreal, Canada
    Acta Cardiol 63:347-53. 2008
    ..Our objective was to assess the potential relationship between AHR and coronary atherosclerosis plaque volume as assessed by 3-dimensional intravascular ultrasound (IVUS)...
  74. ncbi Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease
    Francisco Javier Apullan
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 102:375-9. 2008
    ..49, p = 0.03 for all-cause mortality; adjusted HR 1.25, 95% CI 0.99 to 1.57, p = 0.05 for CV mortality). In conclusion, leisure-time physical activity independently predicted long-term survival in men and women with chronic stable CHD...
  75. ncbi Exercise above the ischemic threshold and serum markers of myocardial injury
    Martin Juneau
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 25:e338-41. 2009
    ..For patients with a relatively low ischemic threshold, this recommendation does not allow for a sufficient training stimulus...
  76. ncbi Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure
    Tae Joon Cha
    5000 Belanger St East, Montreal, Quebec, H1T 1C8, Canada
    Circulation 109:412-8. 2004
    ..The relative importance of ionic versus structural remodeling in CHF-related atrial fibrillation (AF) is controversial...
  77. ncbi Effects of anesthetic induction in patients with diastolic dysfunction
    Pierre Couture
    Department of Anesthesiology, Montreal Heart Institute and Universite de Montreal, 5000 Belanger Street, Montreal, QC, H1T1C8, Canada
    Can J Anaesth 56:357-65. 2009
    ..To evaluate the effects of anesthetic induction on bi-ventricular function in patients with known preoperative left ventricular (LV) diastolic dysfunction undergoing coronary artery bypass grafting surgery (CABG)...
  78. ncbi Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure
    Bao Hua Jiang
    Research Center of the Montreal Heart Institute and Department of Medicine, Universite de Montreal, Montreal, Quebec Canada
    J Card Fail 16:679-88. 2010
    ..We hypothesized that statins could improve pulmonary hypertension and right ventricular function in ischemic CHF by reducing lung remodeling...
  79. ncbi Clinical results with AGI-1067: a novel antioxidant vascular protectant
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec, Canada
    Am J Cardiol 91:41A-49A. 2003
    ....
  80. ncbi Physiological stress responses in defensive individuals: age and sex matter
    Karine Levesque
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Psychophysiology 47:332-41. 2010
    ..02). In conclusion, greater defensiveness was associated with increased reactivity to stress in women whereas in older men, lower defensiveness was associated with elevated cardiovascular, autonomic, and endocrine responses to stress...
  81. ncbi Effect of inhibition of the Na+/H+ exchanger with cariporide on left ventricular function in acute coronary syndromes: results from the echocardiographic substudy of the GUARDIAN trial
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute, Montreal, Quebec
    Can J Cardiol 20:317-22. 2004
    ....
  82. ncbi Three-dimensional trajectory assessment of an IVUS transducer from single-plane cineangiograms: a phantom study
    Denis Sherknies
    Department of Computer Science and Operations Research, University of Montreal, Montreal, QC H3T IJ4, Canada
    IEEE Trans Biomed Eng 52:543-9. 2005
    ..The method is described and validated on two helical vessel phantoms, giving on average a reconstructed path that is less than 2 mm distant from the true path when using full-perspective projection...
  83. ncbi Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF)
    Maryse Palardy
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 24:709-13. 2008
    ....
  84. ncbi Neutrophil adhesion on endothelial cells in a novel asymmetric stenosis model: effect of wall shear stress gradients
    Leonie Rouleau
    Department of Chemical Engineering, McGill University, Montreal, QC, Canada
    Ann Biomed Eng 38:2791-804. 2010
    ..This work suggests an important role for neutrophil-EC interactions in the atherosclerotic process, especially in wall shear stress gradient regions. This is important clinically, potentially helping to explain plaque stability...
  85. ncbi Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease
    Anil Nigam
    Montreal Heart Institute, Universite de Montreal, Montreal, Canada
    Can J Cardiol 23:873-8. 2007
    ..Postprandial glycemia may be a stronger CAD risk factor than fasting glycemia in patients without documented heart disease...
  86. ncbi Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome
    Josep Rodes-Cabau
    Quebec Heart and Lung Institute, Quebec, Canada
    Am J Cardiol 104:750-7. 2009
    ..This effect was in part associated with decreases in atherogenic lipid and inflammatory parameters. These results provide insight into the rapid clinical benefits of statin therapy after an ACS...
  87. ncbi Mechanical characterization of atherosclerotic arteries using finite-element modeling: feasibility study on mock arteries
    Valérie Pazos
    Department of Mechanical Engineering, McGill University, Montreal, QC H3A 2K6, Canada
    IEEE Trans Biomed Eng 57:1520-8. 2010
    ..The method was first tested on a single-layer polyvinyl alcohol (PVA) cryogel stenotic vessel, and then, applied on a double-layered PVA cryogel stenotic vessel with a lipid inclusion...
  88. ncbi Evaluation of coronary atheroma by 64-slice multidetector computed tomography: Comparison with intravascular ultrasound and angiography
    P Ugolini
    Montreal Heart Institute, Montreal, Canada
    Can J Cardiol 25:641-7. 2009
    ..Previous studies have reported an underestimation of plaque burden by MDCT. Whether shorter scan times can allow correct assessment of plaque volume requires comparison with intravascular ultrasound (IVUS)...
  89. ncbi Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
    Raed Osman
    Department of Medicine, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
    Vasc Health Risk Manag 2:221-37. 2006
    ..Therapeutic interventions to decrease circulating levels of CRP are also reviewed...
  90. ncbi Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
    Ariel Diaz
    Department of Medicine, Research Center, Montreal Heart Institute, 5000 Belanger Street E, H1T 1C8 Montreal, Canada
    Eur Heart J 26:967-74. 2005
    ..001 for both). CONCLUSION: Resting heart rate is a simple measurement with prognostic implications. High resting heart rate is a predictor for total and cardiovascular mortality independent of other risk factors in patients with CAD...
  91. ncbi Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial
    Hai Shiang Lee
    Department of Medicine, Montreal Heart Institute, Quebec
    Can J Cardiol 18:271-5. 2002
    ..48. In contrast, probucol significantly influenced the change in EEM over time (P=0.003). CONCLUSION: Plaque composition at the dilated site does not appear to influence probucol-induced vascular remodelling after angioplasty...
  92. ncbi Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation
    Anique Ducharme
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    J Am Coll Cardiol 44:159-64. 2004
    ..CONCLUSIONS: Angiotensin-converting enzyme inhibition was associated with a reduced incidence of AF for patients with hypertension in a usual care setting. These results need to be confirmed in a large-scale randomized clinical trial...
  93. ncbi Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure
    Martine Blanchet
    Department of Medicine, Division of Cardiology, Montreal Heart Institute, Montreal, Quebec, Canada
    Am Heart J 149:938.e1-7. 2005
    ..This beneficial effect is observed despite no significant changes in maximal exercise capacity, and in resting or exercise-induced increase in neurohumoral activation...
  94. ncbi Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats
    Suhayla Mukaddam-Daher
    University of Montreal Hospital Research Center CRCHUM, Montreal, Quebec, Canada
    Hypertension 53:775-81. 2009
    ....
  95. ncbi High-density lipoprotein/apolipoprotein A-I infusion therapy
    Jean Claude Tardif
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    Curr Atheroscler Rep 11:58-63. 2009
    ..This review addresses the potential of HDL and/or apoA-I infusions as a possible therapeutic strategy for the treatment of coronary artery disease...
  96. ncbi Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study
    Philippe L L'Allier
    Department of Medicine, Montreal Heart Institute and Universite de Montreal, Montreal, Quebec, Canada
    J Am Coll Cardiol 51:1066-72. 2008
    ..The objective of this study was to compare the level of platelet inhibition achieved by 3 different clopidogrel loading regimens in patients undergoing elective angiography and percutaneous coronary intervention when appropriate...
  97. ncbi Biventricular diastolic filling patterns after coronary artery bypass graft surgery
    Yanfen Shi
    Department of Medicine, Montreal Heart Institute, and University of Montreal, Montreal, Quebec, Canada
    J Thorac Cardiovasc Surg 131:1080-6. 2006
    ..CONCLUSIONS: In patients with preoperative left ventricular diastolic dysfunction, biventricular filling patterns are impaired initially but return to preoperative status 6 months after coronary artery bypass grafting...
  98. ncbi Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials
    Emmanuelle Vermes
    Department of Medicine, Montreal Heart Institute, Montreal, Canada
    Circulation 107:2926-31. 2003
    ..22; 95% CI, 0.11 to 0.44; P<0.0001). CONCLUSIONS: Treatment with the ACEi enalapril markedly reduces the risk of development of atrial fibrillation in patients with left ventricular dysfunction...
  99. ncbi Mitral Doppler indices are superior to two-dimensional echocardiographic and hemodynamic variables in predicting responsiveness of cardiac output to a rapid intravenous infusion of colloid
    Robert Lattik
    Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada
    Anesth Analg 94:1092-9, table of contents. 2002
    ....
  100. ncbi Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease
    Anil Nigam
    Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
    Am J Cardiol 92:395-9. 2003
    ..An increase in large conduit vessel stiffness may represent either a cause or consequence of endothelial dysfunction and may explain why elevated pulse pressure is a new cardiovascular risk factor...
  101. ncbi Absence of association between infectious agents and endothelial function in healthy young men
    Paul Khairy
    Department of Medicine, Montreal Heart Institute, University of Montreal, Quebec, Canada
    Circulation 107:1966-71. 2003
    ..These results do not preclude active involvement at later stages of the pathophysiological process, such as acceleration of existing atherosclerosis and acute plaque rupture...